Price $1.61 |
Market Cap
330.6M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
19.78
|
P/S
-
|
Dividend %
-
|
|
P/CF
32.7
|
P/FCF
-
|
Op. Cash Flow
-14.7K
|
FCF
-
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-173.80%
|
ROI
-
|
|
ROA
-107.50%
|
EPS Growth
12.80%
|
Current Ratio
10.3
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AEterna Zentaris Inc. (USA) (AEZS) | $0.95 | - | - | 133.3M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $2.88 | - | - | 45.2M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $66.32 | - | 3.10% | 141.03B | Strong Buy |
| Amneal Pharmaceuticals Inc (AMRX) | $5.81 | - | - | 2.02B | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.11 | - | - | 12.5B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
